QUIDELORTHO CORP Debt Securities, Available-for-sale
QUIDELORTHO CORP (QDEL) had Debt Securities, Available-for-sale of $0 as of 2024-09-29, per its 10-Q filed 2024-11-08.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2024-11-08
- 2024-09-29: Debt Securities, Available-for-sale $0.00.
- 2024-06-30: Debt Securities, Available-for-sale $0.00.
- 2024-03-31: Debt Securities, Available-for-sale $0.00.
- 2023-12-31: Debt Securities, Available-for-sale $55.80M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2024-09-29 | $0.00 10-Q · filed 2024-11-08 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-01 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 |
| 2023-12-31 | $55.80M 10-Q · filed 2024-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |